Rothwell Investment Advisors, LLC’s Milestone Pharmaceuticals MIST Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$519	Buy	+600	New	+$666	﹤0.01%	1093

Other funds holding MIST

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

October Effect Virginia Beach, Virginia $98.3M AUM 66.25% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.34B AUM 13.98% 1-Year Est. Return

Stephenson & Company San Clemente, California $220M AUM 8.29% 1-Year Est. Return

Taylor Financial Group Roanoke, Virginia $183M AUM 11.95% 1-Year Est. Return

Rothwell Investment Advisors, LLC's MIST Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Milestone Pharmaceuticals (MIST) in Q3 2026: 600 shares worth $519. The stake represents ﹤0.01% of the portfolio and ranks #1093 among its holdings.

23 funds tracked by Wall St. Rank hold MIST as of Q3 2026.

Rothwell Investment Advisors, LLC held 600 shares of Milestone Pharmaceuticals worth $519 as of Q3 2026.
Milestone Pharmaceuticals was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Milestone Pharmaceuticals made up ﹤0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #1093 holding.
23 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.